Efficient gene delivery targeted to the brain using a transferrin- conjugated polyethyleneglycol-modified polyamidoamine dendrimer

FASEB Journal

Volumn 21, Issue 4, 2007, Pages 1117-1125

  Huang, Rong Qin ^a   Qu, Ying Hua ^a   Ke, Wei Lun ^a   Zhu, Jian Hua ^a   Pei, Yuan Ying ^a   Jiang, Chen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Brain targeting; PAMAM; Transferrin

Indexed keywords

DEOXYRIBONUCLEASE; IODINE 125; LUCIFERASE; MACROGOL; POLYAMIDOAMINE; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE TARGETING; GENE VECTOR; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD-BRAIN BARRIER; BRAIN; CATIONS; CELL LINE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MALE; MICE; MICE, INBRED BALB C; POLYAMINES; POLYETHYLENE GLYCOLS; TRANSFERRIN;

MUS;

EID: 33947625559     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7380com     Document Type: Article

References (34)

1. Smith, M. W., and Gumbleton, M. (2006) Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies. J. Drug Target. 14, 191-214
2. Pardridge, W. M. (2001) Crossing the blood-brain barrier: are we getting it right? Drug Discov. Today 6, 1-2
3. Pardridge, W. M. (2002) The lack of BBB research. Drug Discov. Today 7, 223-226
4. Schlachetzki, F., Zhang, Y., Boado, R., and Pardridge, W. M. (2004) Gene therapy of the brain: the trans-vascular approach. Neurology 62, 1275-1281
5. Pardridge, W. M. (2002) Drug and gene delivery to the brain: the vascular route. Neuron 36, 555-558
6. Pardridge, W. M. (2001) Brain drug targeting and gene technologies. Jpn. J. Pharmacol. 87, 97-103
7. Qian, Z. M., Li, H., Sun, H., and Ho, K. (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54, 561-587
8. Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., and Harashima, H. (2004) Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int. J. Pharm. 281, 25-33
9. Pardridge, W. M. (1999) Blood-brain barrier biology and methodology. J. Neurovirol. 5, 556-569
10. Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., and Mason, D. Y. (1984) Transferrin receptor on endothelium of brain capillaries. Nature 312, 162-163
11. Shi, N., and Pardridge, W. M. (2000) Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. U. S. A. 97, 7567-7572
12. Zhang, Y., Schlachetzki, F., and Pardridge, W. M. (2003) Global non-viral gene transfer to the primate brain following intravenous administration. Mol. Ther. 7, 11-18
13. Olivier, J. C., Huertas, R., Lee, H. J., Calon, F., and Pardridge, W. M. (2002) Synthesis of pegylated immunonanoparticles. Pharm. Res. 19, 1137-1143
14. Bhadra, D., Bhadra, S., Jain, S., and Jain, N. K. (2003) A pegylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm. 257, 111-124
15. Cheng, Y., Xu, T., and Fu, R. (2005) Polyamidoamine dendrimers used as solubility enhancers of ketoprofen. Eur. J. Med. Chem. 40, 1390-1393
16. Kang, H., DeLong, R., Fisher, M. H., and Juliano, R. L. (2005) Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm. Res. 22, 2099-2106
17. Bielinska, A. U., Chen, C., Johnson, J., and Baker, J. R., Jr. (1999) DNA complexing with polyamidoamine dendrimers: implications for transfection. Bioconjug. Chem. 10, 843-850
18. Luo, D., Haverstick, K., Belcheva, N., Han, E., and Saltzman, W. M. (2002) Poly(ethylene glycon)-conjugated PAMAM dendrimer for biocompatible high-efficiency DNA delivery. Macromolecules 35, 3456-3462
19. Braun, C. S., Vetro, J. A., Tomalia, D. A., Koe, G. S., Koe, J. G., and Middaugh, C. R. (2005) Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J. Pharm. Sci. 94, 423-436
20. Choi, J. S., Nam, K., Park, J., Kim, J. B., Lee, J. K., and Park, J. (2004) Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginine. J. Control. Release 99, 445-456
21. Xie, Y., Ye, L. Y., Zhang, X. B., Cui, W., Lou, J. N., Nagai, T., and Hou, X. P. (2005) Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: In vitro and in vivo studies. J. Control. Release 105, 106-119
22. 125I by the conjugation method. Nucl. Technol. 19, 309-313
23. Lu, W., Zhang, Y., Tan, Y. Z., Hu, K. L., Jiang, X. G., and Fu, S. K. (2005) Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J. Control. Release 107, 428-448
24. Ellmann, G. L. (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77
25. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
26. Li, H., and Qian, Z. M. (2002) Transferrin/transferrin receptor-mediated drug delivery. Med. Res. Rev. 22, 225-250
27. Eichman, J. D., Bielinska, A. U., Kukowska-Latallo, J. F., and Baker, J. R., Jr. (2000) The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharm. Sci. Technol. Today 3, 232-245
28. Majoros, I. J., Thomas, T. P., Mehta, C. B., and Baker, J. R., Jr. (2005) Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 48, 5892-5899
29. Youk, H. J., Lee, E., Choi, M. K., Lee, Y. J., Chung, J. H., Kim, S. H., Lee, C. H., and Lim, S. J. (2005) Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. J. Control. Release 107, 43-52
30. Kobayashi, H., Wu, C., Kim, M. K., Paik, C. H., Carrasquillo, J. A., and Brechbiel, M. W. (1999) Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-tac monoclonal antibody. Bioconjug. Chem. 10, 103-111
31. Harashima, H., Shinohara, Y., and Kiwada, H. (2001) Intracellular control of gene trafficking using liposomes as drug carriers. Eur. J. Pharm. Sci. 13, 85-89
32. Sako, K., Okuma, Y., Hosoi, T., and Nomura, Y. (2005) STAT3 activation and c-FOS expression in the brain following peripheral administration of bacterial DNA. J. Neuroimmunol. 158, 40-49
33. Ding, J. J., Guo, C. Y., Cai, Q. L., Lin, Y. H., and Wang, H. (2005) In vivo expression of green fluorescent protein gene and immunogenicity of ES312 vaccine both mediated by Starburst™ polyamidoamine dencrimers. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27, 499-503
34. Kitchens, K. M., El-Sayed, M. E., and Ghandehari, H. (2005) Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv. Drug Deliv. Rev. 57, 2163-2176